CureVac N.V. (CVAC)
NASDAQ: CVAC · IEX Real-Time Price · USD
2.310
-0.200 (-7.97%)
At close: Apr 25, 2024, 4:00 PM
2.340
+0.030 (1.30%)
After-hours: Apr 25, 2024, 7:45 PM EDT
CureVac Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for CureVac stock have an average target of 6.00, with a low estimate of 4.00 and a high estimate of 8.00. The average target predicts an increase of 159.74% from the current stock price of 2.31.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for CureVac stock from 3 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 | 0 |
Buy | 2 | 2 | 2 | 2 | 2 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 | 2 |
Sell | 1 | 1 | 1 | 1 | 1 | 1 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 5 | 5 | 5 | 5 | 5 | 3 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Leerink Partners | Leerink Partners | Buy → Hold Downgrades $12 → $4 | Buy → Hold | Downgrades | $12 → $4 | +73.16% | Apr 25, 2024 |
Guggenheim | Guggenheim | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Apr 5, 2024 |
B of A Securities | B of A Securities | Sell Maintains $10 → $8 | Sell | Maintains | $10 → $8 | +246.32% | Aug 21, 2023 |
SVB Securities | SVB Securities | Buy Initiates $13 | Buy | Initiates | $13 | +462.77% | Jun 8, 2023 |
JMP Securities | JMP Securities | Buy Maintains $34 → $24 | Buy | Maintains | $34 → $24 | +938.96% | Apr 26, 2023 |
Financial Forecast
Revenue This Year
56.55M
from 67.42M
Decreased by -16.12%
Revenue Next Year
71.91M
from 56.55M
Increased by 27.16%
EPS This Year
-0.98
from -1.32
EPS Next Year
-0.93
from -0.98
Revenue Forecast
Revenue | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|---|
High | 108.2M | 171.2M | 253.4M | 661.1M | 550.4M | 678.1M |
Avg | 56.6M | 71.9M | 91.9M | 269.9M | 269.7M | 339.8M |
Low | n/a | n/a | 11.1M | 39.7M | 39.7M | 39.7M |
Revenue Growth
Revenue Growth | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|---|
High | 60.4% | 202.6% | 252.4% | 619.4% | 103.9% | 151.4% |
Avg | -16.1% | 27.2% | 27.8% | 193.7% | -0.1% | 26.0% |
Low | - | - | -84.6% | -56.8% | -85.3% | -85.3% |
EPS Forecast
EPS | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|---|
High | -0.87 | -0.53 | -0.18 | -0.02 | 0.44 | 0.82 |
Avg | -0.98 | -0.93 | -0.74 | -0.66 | -0.27 | -0.05 |
Low | -1.09 | -1.28 | -1.18 | -0.96 | -0.69 | -0.71 |
EPS Growth
EPS Growth | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|---|
High | - | - | - | - | - | - |
Avg | - | - | - | - | - | - |
Low | - | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.